UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 12 von 417
Datensatz exportieren als...
BibTeX
MRI Outperforms [18F]AV‐1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy
Movement disorders, 2019-01, Vol.34 (1), p.105-113
Whitwell, Jennifer L.
Tosakulwong, Nirubol
Schwarz, Christopher G.
Botha, Hugo
Senjem, Matthew L.
Spychalla, Anthony J.
Ahlskog, J. Eric
Knopman, David S.
Petersen, Ronald C.
Jack, Clifford R.
Lowe, Val J.
Josephs, Keith A.
2019
Details
Autor(en) / Beteiligte
Whitwell, Jennifer L.
Tosakulwong, Nirubol
Schwarz, Christopher G.
Botha, Hugo
Senjem, Matthew L.
Spychalla, Anthony J.
Ahlskog, J. Eric
Knopman, David S.
Petersen, Ronald C.
Jack, Clifford R.
Lowe, Val J.
Josephs, Keith A.
Titel
MRI Outperforms [18F]AV‐1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy
Ist Teil von
Movement disorders, 2019-01, Vol.34 (1), p.105-113
Ort / Verlag
Hoboken, USA: John Wiley & Sons, Inc
Erscheinungsjahr
2019
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
Background Elevated uptake of the [18F]AV‐1451 tau‐PET ligand has been observed cross‐sectionally in subjects with progressive supranuclear palsy (PSP). However, it is unknown how the ligand performs longitudinally in PSP. We aimed to determine how regional measures of change on [18F]AV‐1451 PET perform as longitudinal biomarkers of PSP compared with the more established biomarker of rate of midbrain atrophy. Methods Sixteen subjects with PSP underwent 2 serial [18F]AV‐1451 tau‐PET scans and 3‐Tesla MRI over 12 months and were age‐ and sex‐matched to 39 healthy controls with longitudinal [18F]AV‐1451 PET. Median [18F]AV‐1451 uptake was calculated for each scan for regions of interest across the brain and divided by uptake in cerebellar crus to create standard uptake value ratios. Midbrain volume on MRI was also calculated for each scan. Sample sizes required to power placebo‐controlled treatment trials were calculated. Results Rate of midbrain atrophy was significantly increased in PSP compared with controls. [18F]AV‐1451 regional change measures were significantly increased in PSP compared with controls in the pallidum, precentral cortex, dentate nucleus of the cerebellum, and midbrain. Change over time in the PSP Rating Scale correlated with change in midbrain volume but did not correlate with change in the [18F]AV‐1451 measures. Smallest sample‐size estimates were obtained with rate of midbrain atrophy, followed by the PSP Rating Scale, with both outperforming [18F]AV‐1451 measures. Conclusions [18F]AV‐1451 tau‐PET measures increase over time in subjects with PSP, but longitudinal [18F]AV‐1451 measures may not perform as well as rate of midbrain atrophy as biomarkers for PSP clinical trials. © 2018 International Parkinson and Movement Disorder Society
Sprache
Englisch
Identifikatoren
ISSN: 0885-3185
eISSN: 1531-8257
DOI: 10.1002/mds.27546
Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6361527
Format
–
Schlagworte
Aged
,
Aged, 80 and over
,
Atrophy
,
Biomarkers
,
Biomarkers - analysis
,
Carbolines - pharmacology
,
Cerebellum
,
Cerebral Cortex - metabolism
,
Clinical trials
,
Dentate nucleus
,
Female
,
Globus pallidus
,
Globus Pallidus - metabolism
,
Humans
,
Ligands
,
Magnetic resonance imaging
,
Magnetic Resonance Imaging - methods
,
Male
,
Mesencephalon
,
Middle Aged
,
Movement disorders
,
Paralysis
,
Parkinson Disease - diagnostic imaging
,
Positron emission tomography
,
Progressive supranuclear palsy
,
rates
,
Richardson's syndrome
,
serial
,
Supranuclear Palsy, Progressive - diagnosis
,
Supranuclear Palsy, Progressive - metabolism
,
tau
,
tau Proteins - metabolism
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX